| Immune Thrombocytopenia | New England Journal of Medicine | 2019 | 113 |
| Advanced imaging for detection and differentiation of colorectal neoplasia: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2019 | Endoscopy | 2019 | 108 |
| Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer | Annals of Oncology | 2019 | 70 |
| Endoscopic management of polyposis syndromes: European Society of Gastrointestinal Endoscopy (ESGE) Guideline | Endoscopy | 2019 | 67 |
| An experimental strategy unveiling exosomal microRNAs 486-5p, 181a-5p and 30d-5p from hypoxic tumour cells as circulating indicators of high-risk rectal cancer | Journal of Extracellular Vesicles | 2019 | 50 |
| SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study | International Journal of Gynecological Cancer | 2019 | 48 |
| Combination therapies with HSP90 inhibitors against colorectal cancer | Biochimica Et Biophysica Acta: Reviews on Cancer | 2019 | 40 |
| Performance measures for small-bowel endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative | Endoscopy | 2019 | 40 |
| Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy | Annals of Oncology | 2019 | 40 |
| Robot-assisted approach to cervical cancer (RACC): an international multi-center, open-label randomized controlled trial | International Journal of Gynecological Cancer | 2019 | 34 |
| Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer | Translational Oncology | 2019 | 30 |
| EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees† | Annals of Oncology | 2019 | 28 |
| Performance measures for small-bowel endoscopy: A European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative | United European Gastroenterology Journal | 2019 | 27 |
| Quality of life and symptom intensity over time in people with cancer receiving palliative care: Results from the international European Palliative Care Cancer Symptom study | PLoS ONE | 2019 | 23 |
| Chondrosarcoma in Norway 1990-2013; an epidemiological and prognostic observational study of a complete national cohort | Acta Oncológica | 2019 | 22 |
| The emerging role of human cytomegalovirus infection in human carcinogenesis: a review of current evidence and potential therapeutic implications | Oncotarget | 2019 | 22 |
| Modifiable factors affecting older patients' quality of life and physical function during cancer treatment | Journal of Geriatric Oncology | 2019 | 19 |
| Assessing Treatment Response and Prognosis by Serum and Tissue Metabolomics in Breast Cancer Patients | Journal of Proteome Research | 2019 | 19 |
| Frailty identified by geriatric assessment is associated with poor functioning, high symptom burden and increased risk of physical decline in older cancer patients: Prospective observational study | Palliative Medicine | 2019 | 19 |
| miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer | Molecular Oncology | 2019 | 19 |
| Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma | Clinical and Experimental Immunology | 2019 | 18 |
| Endoscopist biopsy rate as a quality indicator for outpatient gastroscopy: a multicenter cohort study with validation | Gastrointestinal Endoscopy | 2019 | 18 |
| Patients with advanced cancer and depression report a significantly higher symptom burden than non-depressed patients | Palliative and Supportive Care | 2019 | 18 |
| Chronic fatigue and associated factors among long-term survivors of cancers in young adulthood | Acta Oncológica | 2019 | 15 |
| Long noncoding RNA MIR31HG is a bona fide prognostic marker with colorectal cancer cell-intrinsic properties | International Journal of Cancer | 2019 | 15 |
